{"id":258950,"date":"2025-09-27T14:33:13","date_gmt":"2025-09-27T14:33:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/258950\/"},"modified":"2025-09-27T14:33:13","modified_gmt":"2025-09-27T14:33:13","slug":"aarp-backs-efforts-to-stop-prescription-drug-shortages","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/258950\/","title":{"rendered":"AARP Backs Efforts to Stop Prescription Drug Shortages"},"content":{"rendered":"

The creation of this stockpile is important because \u201creduced access to needed prescription drugs \u2014 whether due to emergency circumstances, supply chain disruptions or other causes \u2014 can delay or deny critical care or force prescribers to turn to less effective alternatives,\u201d Megan O\u2019Reilly, vice president of health and family for government affairs at AARP, wrote in her letter<\/a> to leaders within the U.S. Department of Health and Human Services on August 26. \u201cWe view this effort as one part of the more comprehensive changes that are needed for a sustainable solution.\u201d\u202f<\/p>\n

Monitoring the supply chain\u202f<\/p>\n

On September 16, AARP chief advocacy and engagement officer Nancy LeaMond sent letters to a bipartisan group of senators and representatives endorsing the Mapping America\u2019s Pharmaceutical Supply, or MAPS, Act. The bill, which has been referred to committees in both the House and Senate, would require federal agencies to coordinate with the private sector and \u201cmap\u201d the entire supply chain of certain essential medicines and identify vulnerabilities \u2014 in other words, to create a clear picture of the producers, manufacturers and other entities involved in manufacturing the drugs from start to finish.\u202f\u202f<\/p>\n

\u201cThis information will play a crucial role in efforts to detect and prevent supply chain disruptions, helping to ensure that patients continue to have access to the medications they need,\u201d LeaMond wrote to Senators<\/a> Gary Peters (D-Mich.), James Lankford (R-Okla.), Joni Ernst (R-Iowa), Tom Cotton (R-Ark.), Tim Kaine (D-Va.), Agnus King, Jr. (I-Maine) and Rick Scott (R-Fla.), as well as Representatives<\/a> Doris Matsui (D-Calif.) and Dan Crenshaw (R-Tex.), who cosponsored these bills.\u202f\u202f<\/p>\n

\"generic-video-poster\"<\/p>\n

Video: AARP Urges Action on Rx Access<\/p>\n

Calling attention to the risks of a drug shortage\u202f<\/p>\n

AARP submitted a statement for the record<\/a> on September 17 to the U.S. Senate Special Committee on Aging, which organized a hearing about vulnerabilities in the drug supply chain and the challenges that drug shortages pose for older Americans.\u202f<\/p>\n

The statement stressed the importance of proactive measures such as an API stockpile, legislation mapping the drug supply chain and bipartisan work within the Senate Finance Committee to stabilize the supply of essential generic medicines.\u202f<\/p>\n

“For those managing health conditions, a stable and secure supply of medications is not just important, it is often life-sustaining,” AARP wrote in the statement. “The federal government can play a vital role in proactively identifying risks and addressing weaknesses in the supply chain before they result in harmful shortages.”<\/p>\n","protected":false},"excerpt":{"rendered":"The creation of this stockpile is important because \u201creduced access to needed prescription drugs \u2014 whether due to…\n","protected":false},"author":3,"featured_media":258951,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[135986,210,1060,135985,11825,135984,67,132,68],"class_list":{"0":"post-258950","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-aarp-prescription-drugs","9":"tag-health","10":"tag-medication","11":"tag-prescription-drug-shortages","12":"tag-prescription-drugs","13":"tag-prescription-medication","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115276756256546241","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/258950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=258950"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/258950\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/258951"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=258950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=258950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=258950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}